Medscape

Management of Choroidal Neovascularization in Myopic Macular Degeneration

Expert Rev Ophthalmol. 2008;3(3):311-323. Choroidal neovascularization in PM has been treated with different approaches, which include laser photocoagulation, submacular surgery, photodynamic therapy ...
The Financial

Bayer Submits Aflibercept Solution for Intravitreal Injection for the Treatment of Myopic Choroidal Neovascularization in the EU

The FINANCIAL — Bayer HealthCare has submitted an application for marketing authorization of aflibercept solution for intravitreal injection for the treatment of myopic choroidal neovascularization ...
Healio

Expanding myopia epidemic likely to result in increasing prevalence of pathologic myopia

Please provide your email address to receive an email when new articles are posted on . The expanding myopia epidemic and the increasing number of children who develop myopia at a young age will ...
PMLiVE

Lucentis cleared in Europe for pathological myopia

Novartis has been given a green light in the EU for the use of its Lucentis product in the treatment of pathological myopia, a major cause of vision loss. Specifically, Lucentis (ranibizumab) has been ...
Medscape

Management of Choroidal Neovascularization in Myopic Macular Degeneration

Expert Rev Ophthalmol. 2008;3(3):311-323. The new and promising strategies for treating CNV include the use of drugs against VEGF, in particular isoform A, which is the most potent promoter of ...